Showing results (81-90 of 108) with videos related to
Sort By:
Pageof 11
JAMA Dermatology|May 14, 2020
Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United StatesMonica E D'Arcy, Ruth M Pfeiffer, Donna R Rivera, et al.Journal for Immunotherapy of Cancer|January 20, 2018
Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trialHoward L Kaufman, Jeffery S Russell, Omid Hamid, et al.Development (Cambridge, England)|October 28, 2010
Hedgehog signaling regulates the generation of ameloblast progenitors in the continuously growing mouse incisorKerstin Seidel, Christina P Ahn, David Lyons, et al.Journal of the American Academy of Dermatology|November 16, 2025
Population differences in Merkel cell carcinoma by virus status and anatomic site: A multi-cohort analysis including institutional, SEER, and NCDB dataMackenzie R Martin, Serena M Vilasi, Yoshine Saito, et al.JAMA Dermatology|November 27, 2024
Merkel Cell Carcinoma and Immunosuppression, UV Radiation, and Merkel Cell PolyomavirusJacob T Tribble, Ruth M Pfeiffer, Isaac Brownell, et al.Cancer Immunology, Immunotherapy : CII|June 17, 2026
Bintrafusp alfa for patients with recurrent or metastatic olfactory neuroblastomaNyall R London, Dara Bracken-Clarke, Elisabetta Xue, et al.Cancer Immunology, Immunotherapy : CII|February 6, 2019
Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinomaSandra P D'Angelo, Matthias Hunger, Andrew S Brohl, et al.The Journal of Investigative Dermatology|June 4, 2026
Expansion of pathogens and restoration of human skin microbiome in CD4 T-cell lymphopeniaJungmin Han, Andrea Lisco, You Che, et al.Journal for Immunotherapy of Cancer|May 17, 2020
Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trialSandra P D'Angelo, Shailender Bhatia, Andrew S Brohl, et al.The Lancet. Oncology|September 6, 2016
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trialHoward L Kaufman, Jeffery Russell, Omid Hamid, et al.Pageof 11